Genentech
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group.[9][12] Boyer worked with Arthur Riggs and Keiichi Itakura from the Beckman Research Institute, and the group became the first to successfully express a human gene in bacteria when they produced the hormone somatostatin in 1977.In June 2007, Genentech began the construction and development of an E. coli manufacturing facility, also in Singapore, for the worldwide production of Lucentis (ranibizumab injection) bulk drug substance.[32][33] Genentech is a donor to the Center for Health Care Strategies, a non-governmental organization that lobbies the United States Government on issues related to Medicaid.Representatives, Joe Wilson and Blaine Luetkemeyer, both issued the same written statements: "One of the reasons I have long supported the U.S. biotechnology industry is that it is a homegrown success story that has been an engine of job creation in this country.
SubsidiaryTraded asNasdaqBiotechnologySouth San FranciscoCaliforniaLevi GarrawaySeverin SchwanchairmanAviv RegevAvastinHerceptinRituxanPerjetaKadcylaGazyvaTarcevaOcrevusPolivyTecentriqXofluzaHemlibraVenclextaEsbrietCotellicAlecensaZelborafNutropinActemraLucentisXolairActivaseCathflo ActivaseXelodaBonivaTNKaseCellCeptPegasysPulmozymeTamifluValcyteAnaproxCytoveneEC-NaprosynErivedgeFuzeonInviraseKlonopinKytrilNaprosynRocephinRomaziconValiumXenicalZenapaxParentcorporationSouth San Francisco, CaliforniaRoche GroupRobert A. SwansonHerbert Boyerrecombinant DNAStanley Norman Cohenrestriction enzymesplasmid vectorArthur RiggsKeiichi ItakuraBeckman Research InstituteexpressbacteriahormonesomatostatinDavid GoeddelinsulinF. Hoffmann-La Roche AGobinutuzumabUniversity of California, San Franciscodrug discoverycheckpoint inhibitorsThe Data Incubator23andMetazemetostatatezolizumabdiscover new candidatesdevelopBioLineRxcheckpoint inhibitorVacaville, CaliforniaOceanside, CaliforniaHillsboro, OregonPorriñoSingaporeranibizumabUnited States GovernmentMedicaidPolitical Action CommitteeProtropinsomatotropindwarfismUniversity of California General FundThe New York Timeshealth care reformCongressU.S. RepresentativesJoe WilsonBlaine LuetkemeyerU.S. Food and Drug AdministrationEli Lilly and CompanyHumulingrowth hormonegrowth hormone deficiencytissue plasminogen activatormyocardial infarctionActimmuneinterferon gamma 1bchronic granulomatous diseasekidney transplantchronic kidney diseasecystic fibrosisnon-Hodgkin's lymphomasrheumatoid arthritismetastatic breast cancerClot-bustingasthmaRaptivaT cells